CONFLUENT AND RETICULATE PAPILLOMATOSIS

CONFLUENT AND RETICULATE PAPILLOMATOSIS was reported 12 times

CONFLUENT AND RETICULATE PAPILLOMATOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Provitamin D2 Compound [EPC] 1 0.0000
1 Interleukin-17A Antagonist [EPC] 1 0.0000
2 Microtubule Inhibitor [EPC] 4 0.0000
3 Platinum-based Drug [EPC] 4 0.0000
4 Purine Antimetabolite [EPC] 1 0.0000
5 Aromatase Inhibitor [EPC] 1 0.0000
6 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
7 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
8 Estrogen [EPC] 1 0.0000
9 RANK Ligand Inhibitor [EPC] 1 0.0000
10 Retinoid [EPC] 1 0.0000
11 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
12 Corticosteroid [EPC] 2 0.0000
13 Tumor Necrosis Factor Blocker [EPC] 1 0.0000